Identification and characterization of a leucine-rich repeat kinase 2 (LRRK2) consensus phosphorylation motif
about
Phosphatases of α-synuclein, LRRK2, and tau: important players in the phosphorylation-dependent pathology of ParkinsonismLRRK2 kinase activity and biology are not uniformly predicted by its autophosphorylation and cellular phosphorylation site statusLRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell modelsLRRK2 directly phosphorylates Akt1 as a possible physiological substrate: impairment of the kinase activity by Parkinson's disease-associated mutationsParkinson-related LRRK2 mutation R1441C/G/H impairs PKA phosphorylation of LRRK2 and disrupts its interaction with 14-3-3An early endosome regulator, Rab5b, is an LRRK2 kinase substrateLRRK2 phosphorylates Snapin and inhibits interaction of Snapin with SNAP-25LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase.G2385R and I2020T Mutations Increase LRRK2 GTPase ActivityProtective LRRK2 R1398H Variant Enhances GTPase and Wnt Signaling Activity.Arsenite stress down-regulates phosphorylation and 14-3-3 binding of leucine-rich repeat kinase 2 (LRRK2), promoting self-association and cellular redistributionRole of LRRK2 kinase dysfunction in Parkinson diseaseRole of LRRK2 kinase activity in the pathogenesis of Parkinson's disease.Evaluating LRRK2 genetic variants with unclear pathogenicity.Transcriptional responses to loss or gain of function of the leucine-rich repeat kinase 2 (LRRK2) gene uncover biological processes modulated by LRRK2 activity.Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expressionActivation of FADD-Dependent Neuronal Death Pathways as a Predictor of Pathogenicity for LRRK2 Mutations.Metabolism of peptide reporters in cell lysates and single cellsLeucine-rich repeat kinase 2 (LRRK2) as a potential therapeutic target in Parkinson's disease.The GTPase function of LRRK2.Human leucine-rich repeat kinase 1 and 2: intersecting or unrelated functions?Phosphorylation of LRRK2: from kinase to substrate.Pharmacological inhibition of LRRK2 cellular phosphorylation sites provides insight into LRRK2 biology.Prediction of the repeat domain structures and impact of parkinsonism-associated variations on structure and function of all functional domains of leucine-rich repeat kinase 2 (LRRK2).Cellular processes associated with LRRK2 function and dysfunctionGTP binding regulates cellular localization of Parkinson's disease-associated LRRK2.Phosphorylation of LRRK2 serines 955 and 973 is disrupted by Parkinson's disease mutations and LRRK2 pharmacological inhibition.Phosphoproteomic evaluation of pharmacological inhibition of leucine-rich repeat kinase 2 reveals significant off-target effects of LRRK-2-IN-1.The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway.Human R1441C LRRK2 regulates the synaptic vesicle proteome and phosphoproteome in a Drosophila model of Parkinson's disease.Biochemical characterization of the GTP-sensing protein, CodY of Bacillus anthracis.Regulation of LRRK2 by Phosphatases.LRRK2 Phosphorylation.
P2860
Q21131229-4E1C6B68-2D64-4613-8EA0-765B45EDE2C8Q24300605-48A9631F-554F-4777-82BE-4A38327F7B4BQ24304959-1FF5B42A-AEEE-4CED-B095-DF38BC142F09Q24306239-B7DE05DD-05DB-45DF-B821-90225B449459Q24314472-875F9EE3-3D57-4DFB-8707-C7E42168F8A4Q24315778-F9B5B998-8576-411F-8C54-25CB92B74C78Q24317760-3747528F-A360-41DD-B08E-C2BC0E0DCC0DQ27322966-079FA872-1401-44F4-A0D9-B205F55B09FDQ29347540-6A035547-393E-46A7-BB37-EA003FA923CDQ29347547-032DB8F3-EBA0-41AB-A0A0-ACAC6D7AAFB8Q33985278-216F86B5-9CC8-47F8-BA6F-0373C71D5D6AQ34192817-D8778BEF-16B1-4882-BFCB-AE12F252C9A0Q34300430-C50458CE-6F44-41B8-8426-02A51903ADC1Q35187769-A543EE16-D501-4419-84EF-1238AC7A4672Q35605204-4B20EE13-6E3A-424B-849C-0187E01124BAQ36073860-4D272010-0A4A-40DF-AFD7-887791837E8EQ36188579-C3A4A6B0-7406-4319-AEC6-F3E2B49EE4EFQ36971329-2EC32C75-294B-4862-864B-9C6A899F89C8Q38009436-6FB6BE1F-14CF-4391-8D92-87D99771A944Q38044433-C916FD1F-673A-4208-9969-93229B68CED1Q38044437-33581794-D098-4586-BE39-19F8A1E07C4EQ38044439-C1F94BE0-54C0-4934-B63E-89E8A70F4088Q38044449-A8D6D688-17A0-41CB-ACFF-66DBE46CD6DBQ38182492-4F15AC65-F1CF-4D1C-955F-B3816B6A6311Q38433725-BBF92A89-CE37-4170-AD1A-64DAE39E11DBQ38814476-86253D7B-43E3-437E-B7D2-E3C7E002BFD5Q39457004-8742E14C-BF82-466B-AB52-3F5479C96CC1Q42263195-C4A0EEA8-C5A1-42C8-AD89-1DB49070CE18Q42509261-70B937C0-BBC6-43C3-99EB-ACE565BFA1D0Q48450468-E8076CB8-8B8D-4BC9-94D9-441507899CC3Q50889108-4E499D3C-E5E6-4467-AF68-EBB7B7387D0CQ51082148-BE3CD417-F17A-4D27-99C4-3FAD8A67C683Q51082156-B1ED89A4-5E25-465C-82F7-57559092C044
P2860
Identification and characterization of a leucine-rich repeat kinase 2 (LRRK2) consensus phosphorylation motif
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Identification and characteriz ...... onsensus phosphorylation motif
@ast
Identification and characteriz ...... onsensus phosphorylation motif
@en
Identification and characteriz ...... onsensus phosphorylation motif
@nl
type
label
Identification and characteriz ...... onsensus phosphorylation motif
@ast
Identification and characteriz ...... onsensus phosphorylation motif
@en
Identification and characteriz ...... onsensus phosphorylation motif
@nl
prefLabel
Identification and characteriz ...... onsensus phosphorylation motif
@ast
Identification and characteriz ...... onsensus phosphorylation motif
@en
Identification and characteriz ...... onsensus phosphorylation motif
@nl
P2093
P2860
P3181
P1433
P1476
Identification and characteriz ...... onsensus phosphorylation motif
@en
P2093
Brian Bates
Eugene L Brown
Kerri Lipinski
Peter H Reinhart
Pooja P Pungaliya
Saurabh Sen
Steven P Braithwaite
Vasanti S Anand
Warren D Hirst
Yuchen Bai
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0013672
P407
P577
2010-10-27T00:00:00Z